Ruben Dagda PhD

We are extremely grateful for being part of the ASCEND Business Cohort program. It has been an extremely productive and eye-opening experience for us as going through this program gave us the knowledge, tools, and training that we needed to enable us to pitch our technology to large pharmaceutical companies. The ASCEND program is the starting point to help us develop CNS Curative Technologies LLC and has opened the door to participate in other NIH-funded programs.

Ruben Dagda, PhDCEO of CNS Curative Technologies, LLC
University of Nevada Reno